Aggrenox (Aspirin / Extended-Release Dipyridamole) - Current Clinical Trials

Aggrenox Related Clinical Trials

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme [Active, not recruiting]

Headache Study to Compare Aggrenox Full Dose and Reduced Dose [Completed]

EARLY 3-Months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA [Recruiting]

Vascular Access Clinical Trials Data Coordinating Center [Completed]

Treatment of Supine Hypertension in Autonomic Failure [Recruiting]

Modified-Release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-Resistant Patients [Completed]

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) [Not yet recruiting]

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence [Recruiting]

Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention [Recruiting]